Genomic aberrations include FGFR3 driver mutations, FGFR3 gene amplification, and FGFR3 translocations, which frequently occur in bladder cancer, myeloma, and glioblastoma 4, 5. This evidence concerns the gene FGFR3 and urinary bladder carcinoma.